Defining the Differences Between Episodic Migraine and Chronic Migraine

por Katsarava, Zaza, Buse, Dawn C., Manack, Aubrey N., Lipton, Richard B.
Publicado 2011

Is there a causal relationship between stress and migraine? Current evidence and implications for management

por Stubberud, Anker, Buse, Dawn C., Kristoffersen, Espen Saxhaug, Linde, Mattias, Tronvik, Erling
Publicado 2021

Efficacy and tolerability of oral gastrodin for medication overuse headache (EASTERN): Study protocol for a multicenter randomized double-blind placebo-controlled trial

por Kong, Fanyi, Buse, Dawn C., Geng, Jia, Xu, Jingjing, Liu, Hanxiang, Ma, Shu
Publicado 2023

Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraine

por Buse, Dawn C., Winner, Paul K., Charleston, Larry, Hirman, Joe, Cady, Roger, Brevig, Thomas
Publicado 2022

A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache‐Related Disabil...

por Lipton, Richard B., Manack Adams, Aubrey, Buse, Dawn C., Fanning, Kristina M., Reed, Michael L.
Publicado 2016

Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study

por Cady, Roger, Lipton, Richard B., Buse, Dawn C., Josiassen, Mette Krog, Lindsten, Annika, Ettrup, Anders
Publicado 2022

Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine

por Buse, Dawn C., Yugrakh, Marianna S., Lee, Lulu K., Bell, Jvawnna, Cohen, Joshua M., Lipton, Richard B.
Publicado 2020

Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-relate...

por Boudreau, Guy P, Grosberg, Brian M, McAllister, Peter J, Lipton, Richard B, Buse, Dawn C
Publicado 2015

Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches

por Mannix, Sally, Skalicky, Anne, Buse, Dawn C., Desai, Pooja, Sapra, Sandhya, Ortmeier, Brian, Widnell, Katherine, Hareendran, Asha
Publicado 2016

Effect of fremanezumab on quality of life and productivity in patients with chronic migraine

por Lipton, Richard B., Cohen, Joshua M., Gandhi, Sanjay K., Yang, Ronghua, Yeung, Paul P., Buse, Dawn C.
Publicado 2020

Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate respons...

por Spierings, Egilius L. H., Ning, Xiaoping, Ramirez Campos, Verena, Cohen, Joshua M., Barash, Steve, Buse, Dawn C.
Publicado 2021

Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine

por Ford, Janet H., Ye, Wenyu, Ayer, David W., Mi, Xiaojuan, Bhandari, Swati, Buse, Dawn C., Lipton, Richard B.
Publicado 2023

Family Impact of Migraine: Development of the Impact of Migraine on Partners and Adolescent Children (IMPAC) Scale

por Lipton, Richard B., Buse, Dawn C., Adams, Aubrey Manack, Varon, Sepideh F., Fanning, Kristina M., Reed, Michael L.
Publicado 2017

The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results

por Adams, Aubrey Manack, Serrano, Daniel, Buse, Dawn C, Reed, Michael L, Marske, Valerie, Fanning, Kristina M, Lipton, Richard B
Publicado 2015

Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study

por Lipton, Richard B., Hutchinson, Susan, Ailani, Jessica, Reed, Michael L., Fanning, Kristina M., Manack Adams, Aubrey, Buse, Dawn C.
Publicado 2019

Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study

por Buse, Dawn C., Gandhi, Sanjay K., Cohen, Joshua M., Ramirez-Campos, Verena, Cloud, Blaine, Yang, Ronghua, Cowan, Robert P.
Publicado 2020

Combining patient reported outcomes and EHR data to understand population level treatment needs: correcting for selection bias in the migraine signature study

por Stewart, Walter F., Yan, Xiaowei, Pressman, Alice, Jacobson, Alice, Vaidya, Shruti, Chia, Victoria, Buse, Dawn C., Lipton, Richard B.
Publicado 2021

Burden of migraine related to menses: results from the AMPP study

por Pavlović, Jelena M, Stewart, Walter F, Bruce, Christa A, Gorman, Jennifer A, Sun, Haiyan, Buse, Dawn C, Lipton, Richard B
Publicado 2015

Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety

por Blumenfeld, Andrew M, Tepper, Stewart J, Robbins, Lawrence D, Manack Adams, Aubrey, Buse, Dawn C, Orejudos, Amelia, D Silberstein, Stephen
Publicado 2019

Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study

por Buse, Dawn C., Fanning, Kristina M., Reed, Michael L., Murray, Sharron, Dumas, Paula K., Adams, Aubrey Manack, Lipton, Richard B.
Publicado 2019